BNY Mellon Continental European

A large cap Europe ex UK fund aiming capital growth over the long term.

  • 297.91p
    Price (Inc)

    These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.

  • -
    Price (Acc)

    These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?

  • 0.00%

    Initial charge

    Some funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!

  • 1.50%
    Annual management charge

    This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).

  • 1.66%
    Ongoing charges

    This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.

  • 0.00%

    How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…

Prices as at 18 September 2020, fund data last updated 20 March 2014

The objective of the Fund is to achieve capital growth from a portfolio of predominantly European companies. The manager uses Newton's in-house macro approach combined with analysis at the stock level. The fund invests primarily in large companies across all sectors.

Fund summary

Sector Europe Excluding UK
Structure OEIC
Launched June, 1987
Size £134m
Yield 0.00%
Charging basis Income
Dividends paid 31 Oct


Standard initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 1.50%
Ongoing charges figure 1.66%


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}

Investment process

Manager research

Average monthly relative returns

  • 15/16 0.00%
  • 16/17 0.00%
  • 17/18 0.00%
  • 18/19 -0.52%
  • 19/20 0.00%

Bestinvest MRI

  • 3 years 0.00%
  • 5 years 0.00%
  • Career 0.06%
  • 3 years 0.00%
  • 5 years 0.00%
  • Career 0.00%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Paul Markham

After graduating from the University of Sheffield in 1995 with a BA in Modern Languages, Markham joined Visa International, with responsibilities for French-speaking clients. After a spell at Morgan Stanley, Markham joined Newton in 1998, initially as an International Business Development Executive developing Latin American markets before becoming Head of International Client Services from 1999. He joined the Global Equity team in 2001.

Track record

The track record of Paul Markham in managing mutual funds in this sector is still too short for us to draw any meaningful conclusions and so our assessment is based largely on qualitative aspects.

Periods of worst performance

Absolute -15.00% (March 2006 - July 2006)
Relative -9.00% (April 2005 - November 2005)

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}


Proportion (%)

  • {{chartDataItem.text}}

Top 10 holdings

Data accurate as at 31 July 2020

4.91% Sap Se
4.39% Roche Hldg Ag
3.77% Novartis Ag
3.7% Zurich Insurance Group
3.48% Nestle Sa
3.36% Vivendi
3.33% Worldline
3.12% Asml Holding Nv
2.95% Unilever
2.85% Sanofi
Source: Trustnet

Sector breakdown

Health Care 25.00%
Industrials 16.00%
Consumer Goods 15.00%
Financials 12.00%
Technology 11.00%
Consumer Services 10.00%
Utilities 4.00%
Basic Materials 4.00%
Money Market 2.00%
Oil & Gas 1.00%

Key Investor Information